Barely Significant
← all excerpts

Prediction of Disease Progression to Upfront Pembrolizumab Monotherapy in Advanced Non-Small-Cell Lung Cancer with High PD-L1 Expression Using Baseline CT Disease Quantification and Smoking Pack Years.

Curr Oncol · 2023 · PMC10297400 · PMID 37366902

Europe PMCDOI
1
hedged sentence
0.2000
closest p · 4.0× alpha
0.2000
boldest claim

The sentences

showed a trendp ≤ 0.2not close (p > 0.1)
To restrict the number of variables in the MV analysis, we considered only the variables that showed a trend of significant associationd with PD ( p ≤ 0.2) in the univariate analysis.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.